Haem oxygenase activity in human umbilical cord and rat vascular tissues

Placenta

Volumn 21, Issue 4, 2000, Pages 337-344

  Vreman, H J ^a   Wong, R J ^a   Kim, E C ^a   Nabseth, D C ^a   Marks, G S ^b   Stevenson, D K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CHROMIUM; HEME; MESOPORPHYRIN; OXYGENASE; PROTEIN;

ANIMAL TISSUE; AORTA; ARTICLE; CAVA VEIN; ENZYME ACTIVITY; FEMALE; HEART; HUMAN; HUMAN TISSUE; LIVER; MALE; NONHUMAN; PLACENTA CIRCULATION; PRIORITY JOURNAL; RAT; UMBILICAL CORD; VASCULAR TISSUE;

EID: 0034114951     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0495     Document Type: Article

References (51)

1. Acevedo CH, Ahmed A. Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J Clin Invest. 101:1998;949-955.
2. Appleton SD, Chretien ML, McLaughlin BE, Vreman HJ, Stevenson DK, Brien JF, Nakatsu K, Maurice DH, Marks GS. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos. 27:1999;1214-1219.
3. Chernick RJ, Martasek P, Levere RD, Margreiter R, Abraham NG. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology. 10:1989;365-369.
4. Coceani F, Kelsey L, Seidlitz E, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Rabinovitch M, Ackerley C. Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. Br J Pharmacol. 120:1997;599-608.
5. Cook MN, Nakatsu K, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Brien JF. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. Can J Physiol Pharmacol. 73:1995;515-518.
6. Dennery PA, McDonagh AF, Spitz DR, Rodgers PA, Stevenson DK. Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med. 19:1995;395-404.
7. Dikranian K, Trosheva M, Nikolov S, Bodin P. Nitric-oxide synthase (NOS) in the human umbilical cord vessels: An immunohistochemical study. Acta Histochem. 96:1994;145-153.
8. Docherty JC, Firneisz GD, Schacter BA. Methene bridge carbon atom elimination in oxidative heme degradation catalyzed by heme oxygenase and NADPH-cytochrome P-450 reductase. Arch Biochem Biophys. 235:1984;657-664.
9. Durante W, Schafer AI. Carbon monoxide and vascular cell function (Review). Int J Molec Med. 2:1998;255-262.
10. Furchgott RF, Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: Relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels. 28:1991;52-61.
11. Grundemar L, Johansson MB, Ekelund M, Hogestatt ED. Haem oxygenase activity in blood vessel homogenates as measured by carbon monoxide production. Acta Physiol Scand. 153:1995;203-204.
12. Ignarro LJ, Ballot B, Wood KS. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem. 259:1984;6201-6207.
13. Johnson RA, Colombari E, Colombari DS, Lavesa M, Talman WT, Nasjletti A. Role of endogenous carbon monoxide in central regulation of arterial pressure. Hypertension. 30:1997;962-967.
14. Johnson RA, Kozma F, Colombari E. Carbon monoxide: From toxin to endogenous modulator of cardiovascular functions. Braz J Med Biol Res. 32:1999;1-14.
15. Kozma F, Johnson RA, Zhang F, Yu C, Tong X, Nasjletti A. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol. 276:1999;R1087-1094.
16. Lancaster JR Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA. 91:1994;8137-8141.
17. Lindstrom AD, Anders MW. The effect of phenobarbital and 3-methylcholanthrene treatment on carbon tetrachloride-stimulated heme degradation and carbon monoxide expiration in vivo. Toxicol Lett. 1:1978;307-314.
18. Lowry OH, Rosebrough HJ, Farr AL, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
19. Maines MD. Zinc.protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim Biophys Acta. 673:1981;339-350.
20. Maines MD. Heme Oxygenase: Clinical Applications and Functions. 1992;CRC Press, Boca Raton. p. 276.
21. Maines MD. Carbon monoxide and nitric oxide homology: Differential modulation of heme oxygenases in brain and detection of protein and activity. Methods Enzymol. 268:1996;473-488.
22. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 37:1997;517-554.
23. Marks GS, Brien JF, Nakatsu K, McLaughlin BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci. 12:1991;185-188.
24. Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Nakatsu K, Brien JF, Pang SC. Heme oxygenase activity and immunohistochemical localization in bovine pulmonary artery and vein. J Cardiovasc Pharmacol. 30:1997;1-6.
25. Martasek P, Solangi K, Goodman AI, Levere RD, Chernick RJ, Abraham NG. Properties of human kidney heme oxygenase: Inhibition by synthetic heme analogues and metalloporphyrins. Biochem Biophys Res Commun. 157:1988;480-487.
26. McCoubrey WK Jr, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem. 247:1997;725-732.
27. Mitrione SM, Villalon P, Lutton JD, Levere RD, Abraham NG. Inhibition of human adult and fetal heme oxygenase by new synthetic heme analogues. Am J Med Sci. 296:1988;180-186.
28. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:1991;109-142.
29. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA. 92:1995;1475-1479.
30. Myatt L, Brewer A, Brockman DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol. 164:1991;687-692.
31. Myatt L, Brockman DE, Eis AL, Pollock JS. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta. 14:1993;487-495.
32. Nanaev AK, Kohnen G, Milovanov AP, Domogatsky SP, Kaufman P. Stromal differentiation and architecture of the human umbilical cord. Placenta. 18:1997;53-64.
33. Nowell SA, Leakey JEA, Warren JF, Lang NP, Frame LT. Identification of enzymes responsible for the metabolism of heme in human platelets. J Biol Chem. 273:1998;33 342-33 346.
34. Odrcich MJ, Graham CH, Kimura KA, McLaughlin BE, Marks GS, Nakatsu K, Brien JF. Heme oxygenase and nitric oxide synthase in the placenta of the guinea pig during gestation. Placenta. 19:1998;509-516.
35. Posselt AM, Kwong LK, Vreman HJ, Stevenson DK. Suppression of carbon monoxide excretion rate by tin protoporphyrin. Am J Dis Child. 140:1986;147-150.
36. Seidman DS, Hallak M, Kelley DK, Stevenson DK. The role of carbon monoxide (CO) in the pathogenesis of preeclampsia. J Invest Med. 45:1997;166A.
37. Serfass L, Burstyn JN. Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity. Arch Biochem Biophys. 359:1998;8-16.
38. Snyder SH. Nitric oxide: First in a new class of neurotransmitters. Science. 257:1992;494-496.
39. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1046.
40. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem. 244:1969;6388-6394.
41. Vreman HJ, Ekstrand BC, Stevenson DK. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res. 33:1993;195-200.
42. Vreman HJ, Stevenson DK. Heme oxygenase activity as measured by carbon monoxide production. Anal Biochem. 168:1988;31-38.
43. Vreman HJ, Stevenson DK. Detection of heme oxygenase activity by measurement of CO. Maines MD, Costa LG, Reed DJ, Sassa S, Sipes IG. Current Protocols in Toxicology. 1999;9.2.1-9.2.10 John Wiley & Sons, Inc, New York.
44. Vreman HJ, Stevenson DK, Henton D, Rosenthal P. Correlation of carbon monoxide and bilirubin production by tissue homogenates. J Chromatogr. 427:1988;315-319.
45. Vreman HJ, Wong RJ, Sanesi CA, Dennery PA, Stevenson DK. Simultaneous production of CO and TBARS in rat tissue preparations by an iron/ascorbate system. Can J Physiol Pharmacol. 76:1998a;1057-1065.
46. Vreman HJ, Wong RJ, Williams SA, Stevenson DK. In vitro heme oxygenase isozyme activity inhibition by metalloporphyrins. Pediatr Res. 43:1998b;202A.
47. Wang R. Resurgence of carbon-monoxide: An endogenous gaseous vasorelaxing factor. Can J Physiol Pharmacol. 76:1998;1-15.
48. Wang R, Wang ZZ, Wu LY. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol. 121:1997;927-934.
49. Wolff DG, Bidlack WK. The formation of carbon monoxide during peroxidation of microsomal lipids. Biochem Biophys Res Commun. 73:1976;850-857.
50. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 103:1999;129-135.
51. Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, Snyder SH. Heme oxygenase 2: Endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA. 93:1996;795-798.